Tamsulosin Hydrochloride
Product Images NDC 67296-0955

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67296-0955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Tamsulosin (Ee9d9efd 0c79 4993 Bfd7 D4c30e20bddd 01)

Chemical structure diagram of Tamsulosin Hydrochloride showing its molecular arrangement, including aromatic rings and functional groups such as methoxy, sulfonamide, and hydrochloride components.*

FDA Label Image

Structured Formula For Tamsulosin (Ee9d9efd 0c79 4993 Bfd7 D4c30e20bddd 02)

A line graph showing plasma concentration (mg/mL) over time (hours) for Tamsulosin Hydrochloride under fasted and fed conditions. Time is plotted on the x-axis from 0 to 36 hours, and plasma concentration on the y-axis from 0 to 25 mg/mL. The fasted state shows a higher peak concentration earlier than the fed state, which exhibits a lower, delayed peak.*

FDA Label Image

Structured Formula For Tamsulosin (Ee9d9efd 0c79 4993 Bfd7 D4c30e20bddd 03)

A line graph depicting mean change over duration of treatment in weeks for Tamsulosin Hydrochloride at 0.4 mg and 0.8 mg doses compared to placebo. The graph shows three lines representing placebo, 0.4 mg, and 0.8 mg treatments with sample sizes noted at intervals, illustrating greater mean changes with active treatments over placebo across a 13-week period.*

FDA Label Image

Structured Formula For Tamsulosin (Ee9d9efd 0c79 4993 Bfd7 D4c30e20bddd 04)

A line graph depicting mean change over treatment duration in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The x-axis shows time points from 0 to 13 weeks and LOCF, and the y-axis shows mean change values. The graph includes sample sizes at each time point and demonstrates treatment effects over time.*

FDA Label Image

Structured Formula For Tamsulosin (Ee9d9efd 0c79 4993 Bfd7 D4c30e20bddd 05)

A line graph depicting mean change in a parameter (measured in mL/sec) over the duration of treatment in weeks. It compares three treatment groups: 0.8 mg, 0.4 mg, and placebo, showing mean values at various weekly intervals including baseline and last observation carried forward (LOCF).*

FDA Label Image

Structured Formula For Tamsulosin (Ee9d9efd 0c79 4993 Bfd7 D4c30e20bddd 06)

Line graph showing mean change in mL/sec over duration of treatment in weeks, comparing Tamsulosin Hydrochloride doses of 0.8 mg, 0.4 mg, and placebo. The x-axis represents treatment weeks up to 13 and includes last observation carried forward (LOCF), while the y-axis measures mean change in flow rate from 0 to 3.0 mL/sec.*

FDA Label Image

Tamsulosin HCl Capsules, 0.4 mg (Ee9d9efd 0c79 4993 Bfd7 D4c30e20bddd 07)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, containing 100 capsules. The label displays the product name, strength, and dosage form along with directions for pharmacists to dispense patient information leaflets. The manufacturer is Zydus Lifesciences Ltd., India, and the distributor is Zydus Pharmaceuticals USA Inc., Pennington, NJ. Storage and dosage instructions are briefly noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.